Cargando…

Therapeutic Effects of 25-Hydroxyvitamin D on the Pathological Process of Benign Prostatic Hyperplasia: An In Vitro Evidence

The pathogenesis of benign prostatic hyperplasia (BPH) is extremely complicated which involving the multiple signaling pathways. The deficiency of vitamin D is an important risk factor for BPH, and exogenous vitamin D is effective for the treatment of BPH. In this study, we provided in vitro mechani...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yanbo, Xu, Hui, Liu, Chong, Gu, Meng, Chen, Qi, Zhan, Ming, Wang, Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523287/ https://www.ncbi.nlm.nih.gov/pubmed/34671434 http://dx.doi.org/10.1155/2021/4029470

Ejemplares similares

Exploration of diagnostic biomarkers, microenvironment characteristics, and ursolic acid's therapeutic effect for benign prostate hyperplasia
por: Chen, Yanbo, et al.
Publicado: (2023)

Lack of adiponectin and adiponectin receptor 1 contributes to benign prostatic hyperplasia
por: Fu, Shi, et al.
Publicado: (2017)

Adiponectin deficiency contributes to the development and progression of benign prostatic hyperplasia in obesity
por: Fu, Shi, et al.
Publicado: (2017)

LncRNA DIO3OS regulated by TGF-β1 and resveratrol enhances epithelial mesenchymal transition of benign prostatic hyperplasia epithelial cells and proliferation of prostate stromal cells
por: Chen, Yanbo, et al.
Publicado: (2021)

Smoking habits and benign prostatic hyperplasia: A systematic review and meta-analysis of observational studies
por: Xu, Huan, et al.
Publicado: (2016)

High-Fat Diet Induced Gut Microbiota Alterations Associating With Ghrelin/Jak2/Stat3 Up-Regulation to Promote Benign Prostatic Hyperplasia Development
por: Gu, Meng, et al.
Publicado: (2021)

Therapeutic options in the treatment of benign prostatic hyperplasia
por: Sandhu, Jaspreet S
Publicado: (2009)

Benign Prostatic Hyperplasia
Publicado: (2015)

Measurement of autophagy flux in benign prostatic hyperplasia in vitro
por: Oh, Sung-hee, et al.
Publicado: (2020)

An investigation on the relevance of prolactin, insulin‐like growth factor‐1 and 25‐hydroxyvitamin D(3) (25‐OHD(3)) in canine benign prostatic hyperplasia in a predisposed breed model
por: Werhahn Beining, Franziska, et al.
Publicado: (2021)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

AB067. Transurethral endoscopic treatment of benign prostatic hyperplasia
por: Meng, Qingjun, et al.
Publicado: (2017)

Correlation Between Benign Paroxysmal Positional Vertigo and 25-hydroxyvitamin D
por: Song, Penglong, et al.
Publicado: (2020)

Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia
por: Yu, Haining, et al.
Publicado: (2015)

Vitamin D receptor as a therapeutic target for benign prostatic hyperplasia
por: Manchanda, Parmeet Kaur, et al.
Publicado: (2012)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Eriochloa villosa Alleviates Progression of Benign Prostatic Hyperplasia in vitro and in vivo
por: Baek, Eun Bok, et al.
Publicado: (2022)

Biocompatibility and efficacy of prostatic urethral lift in benign prostate hyperplasia: an in vivo and in vitro study
por: Xia, Yuqi, et al.
Publicado: (2023)

Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
por: Hung, S-C, et al.
Publicado: (2013)

Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasia
por: Dun, Rong-liang, et al.
Publicado: (2022)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

A multicenter retrospective study of transurethral prostate split for benign prostate hyperplasia
por: Wei, Jingchao, et al.
Publicado: (2022)

Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
por: Protopsaltis, Ioannis, et al.
Publicado: (2013)

Ameliorative effect of Abeliophyllum distichum Nakai on benign prostatic hyperplasia in vitro and in vivo
por: Choi, Young-Jin, et al.
Publicado: (2022)

The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys
por: Wang, Wenying, et al.
Publicado: (2015)

Morphological Changes of Benign Prostatic Hyperplasia in Culture
por: McMahon, M. J., et al.
Publicado: (1973)

Benign Prostatic Hyperplasia: from Bench to Clinic
por: Yoo, Tag Keun, et al.
Publicado: (2012)

VASTI THERAPY IN THE MANAGEMENT OF BENIGN PROSTATE HYPERPLASIA
por: Gupta, Shivaji, et al.
Publicado: (1997)

Current Laser Treatments for Benign Prostatic Hyperplasia
por: Son, Hwancheol, et al.
Publicado: (2010)

Benign prostatic hyperplasia: An overview of existing treatment
por: Dhingra, Neelima, et al.
Publicado: (2011)

Unsolved Issues in Managing Benign Prostatic Hyperplasia
por: Oh, Seung-June
Publicado: (2013)

Recent advances in treatment for Benign Prostatic Hyperplasia
por: van Rij, Simon, et al.
Publicado: (2015)

Diagnosis and treatment of benign prostate hyperplasia in Asia
por: Foo, Keong Tatt
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_q3q76nntpj7ifdjqhrk0g7j4b9